This page lists the SEC filings reported by Ayer Capital Management, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2015-05-20 | Ayer Capital Management, LP | Lion Biotechnologies, Inc. | 2,823,333 | 6.3% | EDGAR |
| SC 13G | 2013-06-03 | Ayer Capital Management, LP | Genesis Biopharma, Inc | 560,401,150 | 40.5% | EDGAR |
| SC 13G/A | 2013-05-06 | Ayer Capital Management, LP | InspireMD, Inc. | 855,924 | 2.8% | EDGAR |
| SC 13G/A | 2013-05-06 | Ayer Capital Management, LP | PEREGRINE PHARMACEUTICALS INC | 643,935 | 0.5% | EDGAR |
| SC 13G/A | 2013-03-22 | Ayer Capital Management, LP | BIOSPECIFICS TECHNOLOGIES CORP | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | INSITE VISION INC | 6,584,357 | 5.0% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | InspireMD, Inc. | 1,587,442 | 8.5% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | Oncothyreon Inc. | 2,097,331 | 3.7% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | Celsion CORP | 1,747,145 | 5.0% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | PEREGRINE PHARMACEUTICALS INC | 7,441,442 | 5.6% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | INSITE VISION INC | 6,584,357 | 5.0% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | ACCESS PHARMACEUTICALS INC | 1,207,417 | 5.0% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | ImmunoCellular Therapeutics, Ltd. | 2,089,088 | 4.1% | EDGAR |
| SC 13G/A | 2013-02-15 | Ayer Capital Management, LP | ONCOSEC MEDICAL Inc | 4,411,609 | 5.0% | EDGAR |
| SC 13G/A | 2012-12-07 | Ayer Capital Management, LP | INSMED INC | 1,541,469 | 4.9% | EDGAR |
| SC 13G/A | 2012-12-04 | Ayer Capital Management, LP | PEREGRINE PHARMACEUTICALS INC | 5,743,030 | 5.5% | EDGAR |
| SC 13G | 2012-12-03 | Ayer Capital Management, LP | PEREGRINE PHARMACEUTICALS INC | 3,743,030 | 5.5% | EDGAR |
| SC 13G/A | 2012-10-26 | Ayer Capital Management, LP | ACCESS PHARMACEUTICALS INC | 1,925,433 | 8.0% | EDGAR |
| SC 13G/A | 2012-10-04 | Ayer Capital Management, LP | PEREGRINE PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2012-10-04 | Ayer Capital Management, LP | INSMED INC | 3,116,100 | 10.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.